Dr. Alexis D. Boro, MD

Dr. Boro practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Boro's NPI, 1457436131, was assigned on October 25, 2006. Dr. Boro graduated from Stony Brook University Health Sciences Center School of Medicine in 1998. Dr. Boro holds New York license 225188.

Dr. Boro's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Boro's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Boro to 1 more group practice or clinic, 1 school health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boro practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Boro's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Boro is licensed in New York.

CMS data shows 122 Medicare services from Dr. Boro across 5 procedure codes in 2024, for 99 Medicare patients. Medicare paid $9,849 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 99 Medicare patients who saw Dr. Boro in 2024. The largest group is under 65, with 43 patients. 65% of them have high blood pressure, and 63% have high cholesterol. 78% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boro's median patient age at 57, with 49% women.

In 2024, Dr. Boro wrote 1,477 Medicare Part D claims for 164 patients. 74% of them were for generic drugs. CMS names the drug for 1,353 of them, across 28 drugs with 11 or more claims each, at $571,221 in total drug cost. In 2023, CMS named 1,628 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Boro for performance year 2024, reported as part of a group. CMS lists Dr. Boro as offering telehealth.

Dmand AI links 12 papers to Dr. Boro, published from 2013 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Epilepsy, Electroencephalography and Seizures. Dr. Boro has published most often in Epilepsia Open. Dr. Boro's most frequent co-authors are Daniel Jose Correa, MD, Victor Ferastraoaru, MD and Sheryl R. Haut, MD.

Dmand AI links Dr. Boro to 1 clinical trial. Conditions studied include Epilepsies, Partial and Epilepsy.

CMS Open Payments shows 19 general payments to Dr. Boro from 6 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 76% of the total. Neuropace, Inc. paid the most, $1,346. It also lists 8 research payments totaling $1,300 in 2017.

Dr. Boro graduated from Stony Brook University Health Sciences Center School of Medicine in 1998.